Faghani Roya, Monadi Sahar Darabi, Papalouka Vasiliki, Suaris Tamara
Breast Radiology, Barts Health NHS Trust, London, UK.
Cardiology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Radiol Case Rep. 2025 Jun 11;20(9):4275-4285. doi: 10.1016/j.radcr.2025.05.046. eCollection 2025 Sep.
Contrast-enhanced mammography (CEM) has emerged as a promising technology in the field of breast imaging, experiencing growing acceptance. However, the comparative evaluation of its diagnostic accuracy against MRI remains sparse, largely attributed to its relatively recent introduction. Current studies suggest that MRI and CEM exhibit comparable sensitivity for detecting the index breast lesion. However, there is conflicting evidence regarding their sensitivity in detecting additional breast lesions in cases of known breast cancer, with some studies demonstrating MRI's superiority and others reporting similar sensitivity between the 2 modalities. We present a case where CEM effectively detected a contralateral breast malignancy in a patient with a newly diagnosed breast cancer, whereas it went undetected by MRI initially. Our presentation underscores the importance of more comprehensive research to assess CEM's overall diagnostic capabilities in breast imaging in comparison to MRI, as there may be situations where CEM outperforms MRI.
对比增强乳腺钼靶摄影（CEM）已成为乳腺成像领域一项很有前景的技术，越来越被认可。然而，与MRI相比，其诊断准确性的比较评估仍然很少，这主要归因于它相对较新才被引入。目前的研究表明，MRI和CEM在检测索引乳腺病变方面表现出相当的敏感性。然而，在已知乳腺癌病例中检测其他乳腺病变时，关于它们的敏感性存在相互矛盾的证据，一些研究表明MRI更具优势，而另一些研究报告这两种模式的敏感性相似。我们展示了一个病例，一名新诊断为乳腺癌的患者，CEM有效地检测到了对侧乳腺恶性肿瘤，而MRI最初未检测到。我们的展示强调了进行更全面研究的重要性，以评估CEM与MRI相比在乳腺成像中的整体诊断能力，因为可能存在CEM优于MRI的情况。
